Amyloid Precursor Protein Mediates Neuronal Protection from Rotenone Toxicity.
Kathryn CimdinsHayley S WaughVicki ChrysostomouM Isabel G Lopez SanchezVanessa A JohannsenMark J CookJonathan G CrowstonAndrew F HillJames A DuceAshley I BushIan A TrouncePublished in: Molecular neurobiology (2019)
Mitochondrial complex I dysfunction is the most common respiratory chain defect in human disorders and a hotspot for neurodegenerative diseases. Amyloid precursor protein (APP) and its non-amyloidogenic processing products, in particular soluble APP α (sAPPα), have been shown to provide neuroprotection in models of neuronal injury; however, APP-mediated protection from acute mitochondrial injury has not been previously reported. Here, we use the plant-derived pesticide rotenone, a potent complex I-specific mitochondrial inhibitor, to discover neuroprotective effects of APP and sAPPα in vitro, in neuronal cell lines over-expressing APP, and in vivo, in a retinal neuronal rotenone toxicity mouse model. Our results show that APP over-expression is protective against rotenone toxicity in neurons via sAPPα through an autocrine/paracrine mechanism that involves the Pi3K/Akt pro-survival pathway. APP-/- mice exhibit greater susceptibility to retinal rotenone toxicity, while intravitreal delivery of sAPPα reduces inner retinal neuronal death in wild-type mice following rotenone challenge. We also show a significant decrease in human retinal expression of APP with age. These findings provide insights into the therapeutic potential of non-amyloidogenic processing of APP in complex I-related neurodegeneration.
Keyphrases
- oxidative stress
- diabetic retinopathy
- cerebral ischemia
- optical coherence tomography
- wild type
- endothelial cells
- mouse model
- poor prognosis
- type diabetes
- risk assessment
- optic nerve
- blood brain barrier
- adipose tissue
- small molecule
- brain injury
- high fat diet induced
- protein protein
- drug induced
- skeletal muscle
- oxide nanoparticles
- hepatitis b virus